NCT04184401View on ClinicalTrials.gov

Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Living Donor Liver Transplantation
Interventions
DRUG

Ascites replacement with albumin and hartmann's solution

"Combined strategy for ascites replacement~* 30% of ascites: replacement with 5% albumin~* 40% of ascites: replacement with Hartmann's solution"

DRUG

Ascites replacement with hartmann's solution

"Hartmann's solution only strategy for ascites replacement~\- 70% of ascites: replacement with Hartmann's solution"

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

GC Pharma
All Listed Sponsors
collaborator

GC Pharma

UNKNOWN

lead

Seoul National University Hospital

OTHER

NCT04184401 - Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT | Biotech Hunter | Biotech Hunter